Tyra Biosciences, Inc. Cash Flow Statement

Cash Flow Statement Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Operating Activities
Net Income -9.32M-26.29M-55.33M-69.13M
Depreciation and Depletion 0.05M0.14M0.30M0.40M0.50M
Share-based Compensation 0.44M2.89M10.59M13.53M22.80M
Gains from Investment Securities 0.10M1.24M1.57M4.41M
Cash from Operations -7.76M-23.75M-50.28M-50.14M-69.77M
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF) 0.05M0.14M0.30M0.36M0.52M
Change in Working Capital
Change in Accured Expenses 1.02M1.49M2.36M9.37M-0.74M
Other Working Capital Changes -0.07M2.11M8.24M2.82M0.17M
Investing Activities
Capital Expenditures 0.31M0.66M0.56M0.77M0.66M
Sales of Property, Plant and Equipment 0.02M
Change in Acquisitions & Divestments 165.88M
Cash from Investing Activities -0.31M-0.65M-0.56M-144.60M-98.40M
Financing Activities
Cash from Financing Activities 23.43M311.35M0.63M1.54M202.14M
Additional items
Change in Cash 15.36M286.96M-50.21M-193.21M33.96M
Free Cash Flow -8.07M-24.41M-50.84M-50.91M-70.44M
Net Cash Flow 15.36M286.96M-50.21M-193.21M33.96M